Dr Victoria Cox

PhD candidate


Master in Business Administration (MBA), Quantic School of Business and Technology, 2023; Company Directors Course (GAICD), Australian Institute of Company Directors, 2022; Master in Philosophy (MPhil) in Evidence Based Social Intervention and Policy Evaluation, the University of Oxford, 2019; Diploma in Dermatology (DipDerm), Australian Institute of Dermatology, 2016; Bachelor of Medicine/Bachelor of Surgery (MBBS), University of Adelaide, 2014; Bachelor of Medical Science (BMedSci - First Class Honours), University of Adelaide, 2011

Research Topic:

Healthy skin programs in northern Australia


Darwin – Royal Darwin Hospital campus


Victoria is a PhD research student at the Menzies School of Health Research and a medical doctor at Royal Darwin Hospital in the Northern Territory.

After graduating from medical school at the University of Adelaide in 2014 with First Class Honours, Victoria read for a MPhil in Evidence Based Social Intervention and Policy Evaluation at the University of Oxford as a General Sir John Monash Scholar. Whilst studying at Oxford, she was the Junior Dean of Jesus College and President of the Oxford University Australia New Zealand Society (OUANZ).

Victoria is a Principal Investigator working on a collaborative project to estimate the prevalence and impact of scabies and mass-drug administration treatment programs in remote Aboriginal communities in the Northern Territory, funded by the Australian Centre for the Control and Elimination of Neglected Tropical Diseases (ACE-NTDs). She has championed skin health reform in northern Australia; supporting the development and implementation of community skin health programs, revising national clinical guidelines and co-authoring a successful PBAC submission to change the listing of ivermectin on the Pharmaceutical Benefits Scheme (PBS) for the management of scabies in Aboriginal and Torres Strait Islander populations in Australia.

As the 2024 Northern Territory Fulbright Scholar, Victoria will work with A/Professor Esther Freeman at Massachusetts General Hospital/Harvard Medical School in Boston; developing a roadmap to improve the global provision of skin healthcare as part of the global access to dermatology project.

  1. Cox, V., Fuller, L. C., Engelman, D., Steer, A., & Hay, R. J. (2021). Estimating the global burden of scabies: what else do we need? British Journal of Dermatology (1951), 184(2), 237-242. doi:10.1111/bjd.19170